Olga Grishina

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 719 citations

Life Sciences, Hematology, Immunology +14

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Gèrard Socié, Claudia Schmoor, Wolfgang Bethge et al. · Blood · 2011 · 303 citations · Full text

Life Sciences, Immunology, Clinical Immunology +15

Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial

Jürgen Finke, Claudia Schmoor, Wolfgang Bethge et al. · The Lancet Haematology · 2017 · 112 citations

Life Sciences, Hematology, Immunology +17

Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial

Michael Lübbert, Olga Grishina, Claudia Schmoor et al. · Journal of Clinical Oncology · 2019 · 104 citations

Medicine, Oncology, Pharmacology +11

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)

Elisabeth Schorb, Jürgen Finke, Andrés J.M. Ferreri et al. · BMC Cancer · 2016 · 69 citations · Full text

Medicine, Oncology, Cell Therapy +15